Antiglycation activity of nonvasodilatory beta blockers highlights acebutolol with reduced glycation markers and altered phosphoprotein expression
Scientific Reports - Antiglycation activity of nonvasodilatory beta blockers highlights acebutolol with reduced glycation markers and altered phosphoprotein expression